DONGGUAN, China, 2. März 2025 /PRNewswire/ -- Fapon Biopharma, ein innovatives Biotech-Unternehmen, welches therapeutische Antikörper und Fusionsproteine entwickelt, freut sich bekannt zu geben, dass die US-amerikanische Food and Drug Administration (FDA) den Antrag auf ein neues...
Hence then, the article about fapon biopharma gibt die fda zulassung der ind fur fp008 bekannt eine erste immuntherapie dieser klasse fur solide tumore was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Fapon Biopharma gibt die FDA-Zulassung der IND für FP008 bekannt, eine erste Immuntherapie dieser Klasse für solide Tumore )
Also on site :
- North Korea says its latest weapons tests included missiles with cluster-bomb warheads
- 1987 No. 1 Hit Ranked Among 'Best Hair Metal Songs of All Time' Became a Powerful Anthem for Starting Over
- Man rescued after two weeks trapped in collapsed Mexico mine